| Symbol | KMTS |
|---|---|
| Name | KESTRA MEDICAL TECHNOLOGIES, LTD. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Medical/Dental Instruments |
| Address | 3933 LAKE WASHINGTON BLVD NE,SUITE 200, KIRKLAND, Washington, 98033, United States |
| Telephone | +1 425 279-8002 |
| Fax | — |
| — | |
| Website | https://www.kestramedical.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001877184 |
| Description | Kestra Medical Technologies is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The cornerstone of our Cardiac Recovery System platform is the ASSURE WCD, a next generation wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest. The ASSURE WCD automatically monitors elevated risk patients and, if needed, delivers a defibrillation shock to return the patients heart to normal rhythm. Additional info from NASDAQ: |
Webster Brian Daniel 🔴 sold 15.0K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) at $21.46 Transaction Date: May 15, 2026 | Filing ID: 229188
Read more📋 Webster Brian Daniel (Officer) plans to sell 15K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. (at $20.96 each, total $314K) Filed: May 15, 2026 | ID: 000243
Read moreKestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference
Read moreWebster Brian Daniel 🔴 sold 15.0K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) at $20.04 Transaction Date: Apr 15, 2026 | Filing ID: 159276
Read more📋 Webster Brian Daniel (Officer) plans to sell 15K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. (at $20.04 each, total $301K) Filed: Apr 15, 2026 | ID: 000204
Read moreKestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner
Read moreNew Form SCHEDULE 13G/A - KESTRA MEDICAL TECHNOLOGIES, LTD. <b>Filed:</b> 2026-04-08 <b>AccNo:</b> 0000080255-26-000314 <b>Size:</b> 7 KB
Read moreNew Form S-3ASR - KESTRA MEDICAL TECHNOLOGIES, LTD. <b>Filed:</b> 2026-04-01 <b>AccNo:</b> 0001193125-26-138030 <b>Size:</b> 490 KB
Read moreCOHEN RAYMOND W 🟢 acquired 10.0K shares of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) at $19.98 Transaction Date: Mar 26, 2026 | Filing ID: 132324
Read moreKestra Medical Technologies Named Finalist for 2026 GeekWire “Deal of the Year”
Read more| Trial ID | Title | Phase | Indication | Status | Start Date | Completion Date | Source |
|---|---|---|---|---|---|---|---|
| NCT05135403 | ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS) | — | Sudden Cardiac Arrest | Recruiting | 2021-11-20 | 2025-10-01 | ClinicalTrials.gov |
| NCT04132466 | ASSURE WCD Clinical Evaluation - Conversion Efficacy Study | Na | Death, Sudden, Cardiac | Completed | 2019-11-25 | 2020-03-19 | ClinicalTrials.gov |
| NCT03887052 | ASSURE WCD Clinical Evaluation - Detection and Safety Study | Na | Cardiac Arrest, Sudden | Completed | 2019-03-20 | 2019-06-18 | ClinicalTrials.gov |
| Product Name | Type | Development Stage | Therapeutic Area | Study Status | Trial ID |
|---|---|---|---|---|---|
| Defibrillation | Other | Preclinical | Sudden Cardiac Arrest | RECRUITING | NCT05135403 |
| ASSURE™ Wearable Cardioverter Defibrillator (WCD) | Other | Approved | Cardiac Arrest, Sudden | COMPLETED | NCT03887052 |
| Defibrillation using the ASSURE wearable cardioverter defibrillator therapy delivered via a waveform delivery test system | Drug | Approved | Death, Sudden, Cardiac | COMPLETED | NCT04132466 |